As Parkinson's disease (PD) is a heterogeneous disorder, personalized medicine is truly required to optimize care. In their current form, standard scores from paper and pencil symptom-measures traditionally used to track disease progression are too coarse (discrete) to capture the granularity of the clinical phenomena under consideration, in the face of tremendous symptom diversity. For this reason, sensors, wearables, and mobile devices are increasingly incorporated into PD research and routine care. These digital measures, while more precise, yield data that are less standardized and interpretable than traditional measures, and consequently, the two types of data remain largely siloed. Both of these issues present barriers to the broad clinical application of the field's most precise assessment tools. This protocol addresses both problems. Using traditional tasks to measure cognition and motor control, we test the participant, while co-registering biophysical signals unobtrusively using wearables. We then integrate the scores from traditional paper-and-pencil methods with the digital data that we continuously register. We offer a new standardized data type and unifying statistical platform that enables the dynamic tracking of change in the person's stochastic signatures under different conditions that probe different functional levels of neuromotor control, ranging from voluntary to autonomic. The protocol and standardized statistical framework offer dynamic digital biomarkers of physical and cognitive function in PD that correspond to validated clinical scales, while significantly improving their precision.
Introduction
Precision medicine (PM) (Figure 1 ) has emerged as a powerful platform to develop personalized targeted treatments. In the field of cancer research, this model has been very successful and its tenets are bound to revolutionize the medical field in the near future 1 . PM combines multiple layers of knowledge, ranging from patients' self-reports to genomics. Integrating information across all these layers results in a personalized assessment that enables interpretation of the data and more precise treatment recommendations aimed at considering all aspects of the person's life.
There are several challenges when trying to adapt the PM platform to neuropsychiatric and neurological disorders of the nervous systems 2, 3 The current "grand averaging" approach smooths out as noise the individual's stochastic fluctuations in the data, i.e., the signal variability that manifests as the person naturally ages, as the disorder progresses, and as the person's nervous systems receive and respond to treatments. The lack of normative data (i.e., assessing large cross sectional and longitudinal portions of the healthy population) prevents us from understanding the neurotypical dynamics of healthy aging. As such, it becomes a challenge to know how to more generally anticipate the consequences of a given pathology, as that pathology begins to systemically manifest in the individual. Predictive approaches are critical to design regenerative therapies and/or neuroprotective therapies that slow down the degenerative process. Parkinson's disease is a good example of pathologies whereby the manifestations of the disorder are preceded by many other measurable symptoms. We know today that the visible motor disorders were preceded by less visible sensory issues such as diminished olfactory function 5, 6 , changes in speech patterns, rapid eye movement (REM) sleep 7 , and other non-motor symptoms related to the functioning of the enteric nervous systems 8 . By the time the disorder manifests, there is already high dopaminergic depletion in the system; yet non-motor symptoms could have forecasted some of the visible motor impairments, by which the disorder is currently primarily assessed.
There is a need to change the current analytical models and consider the importance of properly characterizing empirical data across all levels of the nervous systems, whereby biorhythmic motions manifest and can be dynamically harnessed in the form of time series co-registered with a multitude of sensors. Motion data in its more general sense ought not to be limited to movements and the disorders they broadcast. Digital data from all biorhythms of the nervous systems (inclusive of non-movement waveforms) offer the forecasting potential that we may we need to help prevent or to slow down rapid neurodegeneration. Yet, as we augment our repertoire of data types, we should avoid the inherent assumption of parametric linear models for statistical inference and interpretation currently in use to analyze such data. It will be critical to evaluate the adequacy of such linear models for the types of highly non-linear problems that we study in nervous systems pathologies subject to stochastic shifts and dynamical changes. Caveats in current assumption-analysis pipeline loops are present in both data types being harnessed: those from the discrete clinical scores and those from the continuous digital biophysical waveforms. While they remain disconnected, it will be important to design new frameworks that enable proper integration of both types of data in ways that align digital outcomes with clinical criteria to facilitate the use of emerging digital technologies by patients, caregivers and clinicians.
To overcome some of these challenges, we have recently adapted the PM platform in Figure 1 to provide precision phenotyping for neurological and neuropsychiatric conditions 3 . To that end, we have designed a new way to gather, analyze and interpret behavioral data in tandem with traditional clinical scoring tests that ascertain complex relations between cognitive and motor phenomena. More precisely, we have digitized the pencil-and-paper methods. The data from such methods alone are much too coarse to capture important information escaping the naked eye. But their use in combination with digital data from biophysical sensors offers a new avenue to connect new emerging digital technologies with clinical criteria amenable to encourage clinicians to adopt them in the near future.
Here, we introduce the use of digital data within the context of clinical assessments. Namely, as the person performs the clinical task, e.g., drawing a clock in the Montreal Cognitive Assessment (MoCA) test, the biorhythms output by the nervous systems are co-registered across different functional layers. These include electroencephalography (EEG), electrocardiography (ECG or EKG), voice patterns and kinematics from the body, and the kinematic output from the hand-held pen that the person uses to draw the clock on a digitized tablet. We also collect video data from the face as the person draws, to perform sentiment analyses predictive of emotional states. These data are then analyzed through the optics of a new statistical platform for individualized behavioral analysis (SPIBA) and interpreted according to the clinical criteria underlying such tests. More specifically, the discrete scores are used to median-rank the cohort of patients and in this way, stratify the group based on that clinical criteria. We can then examine the continuous biophysical data of the groups thus identified, in search for digitally-driven stochastic criteria that fundamentally separates one subset of patients from another, across more than one parametric dimension. Moreover, by examining the continuous biophysical data in its own right, according to the inherent fluctuations of each person within the cohort and blinded from the clinical criteria, we can search for self-emerging clusters within the cohort, and compare the extent to which such clusters map onto those that the subtypes informed by the clinical criteria revealed.
Protocol
All methods described here have been approved by the Rutgers University Institutional Review Board.
1. Participants and acquisition system set up 1 Figure 2C ). 2. Attach the remaining channel sensor (Oz) to a connector to measure the heart signal, by positioning that connected sensor on the participant's left-side stomach ( Figure 2C ). 3. Attach two reference channel sensors behind the participant's left ear, and then insert electrode gel into the sensors on the EEG cap using a syringe ( Figure 2C ). 4. Once completed, start streaming the electrical activities on the recording software for a few minutes until it stabilizes. NOTE: Figure 2D shows sample traces from the EEG signals harnessed from the central nervous system (CNS) and autonomic nervous system (ANS). 1. Instruct the participant to copy the Benson figure on the paper, and to remember the design because the participant will be asked to draw it again from memory later. NOTE: This test is designed to assess the participant's visuo-constructional and visual memory function ( Figure 4A ). , and assesses processing speed and executive function and depends on visuomotor and perceptual-scanning skills ( Figure 4B ). 6. Conduct tasks 8 and 9 -Number Span Test (Forward and Backward) 13 (10 min).
Conduct tasks 2 and 3 -Trail Making Test Part A (3 min
1. Instruct the participant to repeat the numbers that the experimenter reads out loud. 2. For task 8 (forward), instruct the participant to repeat the numbers in the same order, and for task 9 (backward), to repeat them in the reverse order. For both tests, there are two trials per sequence length ranging from 3 to 9 digits for the forward, and 2 to 8 digits for the backward test. Continue testing until two number strings at the same length are failed. NOTE: Both tests measure the capacity to briefly hold information, but the backward test (task 9) also measures the ability to manipulate the numbers and reverse the sequence. As such, in the context of the present protocol, this task measures a memory and a cognitive component in relation to the voice biorhythms output. 7. Conduct tasks 10, 11, and 12 -Pointing (10 min). 1. Position a target in front of the participant to point and touch. 2. For task 10 (control), instruct the participant to point at the target 40 times at a self-paced manner with the dominant hand. 3. For task 11 (metronome), instruct the participant to point at the target 40 times at a self-paced manner, while setting the metronome beat at 35 bpm in the background, but do not instruct anything about the metronome beat. 4. For task 12 (paced pointing), instruct the participant to point at the target 40 times at the pace following the metronome beat set at 35 bpm. NOTE: The pointing task allows for separating the participant's motion by deliberate (forward movement, from the time the hand is resting until the hand reaches the target) and spontaneous (backward movement, from the time the hand is touching the target until the hand reaches back to its resting position) segments, thereby analyzing the biophysical signals when the participant is exerting voluntary control (deliberate motion), and when the participant is exerting little control (spontaneous motion) ( Figure 5A) . By introducing the metronome beats and requiring the participant to pace the pointing at the metronome beat, comparison can be made of the biophysical signals when the participant is moving at a self-paced manner, and when the participant is actively controlling the movement pace to an external beat.
8. Conduct tasks 13, 14, and 15 -Walking (25 min). 1. Instruct the participant to walk naturally for 5 minutes under three different conditions. 2. For task 13 (control), instruct the participant to walk naturally around the room. 3. For task 14 (metronome), instruct the participant to walk naturally around the room while setting the metronome to beat in the background for 12 bpm. 4. For task 15 (paced breathing), instruct the participant to walk naturally around the room while he/she paces the breathing rate to the metronome beat set at 12 bpm. NOTE: By introducing the metronome beat, comparison can be made of the biophysical signals while the participant is using the entire body to move and breathe at a self-paced manner, and when the participant is actively controlling the breathing pace (which usually occurs automatically) while moving the entire body ( Figure 5B ). 
Representative Results

Parameters of interest
There are many motion parameters that we can extract from the trajectories of biophysical digital signals generated by the person's nervous systems. Here we focus on the electroencephalogram EEG waveforms (representative of the central nervous systems, CNS output), bodily movements (representative of the peripheral nervous systems, the PNS output), and the heart signals (representative of the autonomic nervous systems, ANS output).
For the CNS-and ANS-related signals, we use the fluctuations in peak amplitude of the EEG and ECG waveforms (µV) converted to the unitless (standardized) micro-movement spikes (MMS) (see below). For the PNS-related signals, we use the trajectories of the center of mass (COM) and their speed profiles' time series (m/s), to derive the corresponding unitless MMS. Once we gather the MMS, we can integrate them into a weighted-undirected graph, based on a set of pairwise signal analytics across sensors and levels of nervous systems function. This step enables us to use network connectivity analyses on the combined signals. We then produce interpretable graphs 14, 15 depicting changes in self-emerging network topology. In particular, when we compare these graphs across the three pointing and/or walking tasks, we can observe how the biophysical signals respond to an external rhythm in a passive manner (i.e., when the metronome beats spontaneously entrain the biorhythm) and in an active manner (i.e., when the participant deliberately attempts to pace the hand pointing or the walking motions to the metronome beat). We can also study patterns of information transmission across the network nodes representing the CNS, the PNS and the ANS levels of function.
the amplitudes are normalized to a unitless value ranging in the real [0,1] interval, thus allowing integration and comparison across signals from different functional layers of the nervous systems: CNS, PNS and ANS. These disparate layers of functionality require different levels of neuromotor control and possess different amplitude ranges across individuals. They also have different inter-peak-interval timings. While the MMS normalization conserves the timing of the original peaks, it also captures the variations in the amplitude. Such a normalization is obtained by dividing each local peak amplitude by the sum of the peak amplitude and the average of the signals sampled within the two neighboring local minima surrounding the peak:
These continuous spikes in the [0,1] real numbers interval preserve the information on the timing and amplitude fluctuations, while enabling us to treat the time series as a random process. We then adopt a Gamma process under the general rubric of Poisson random processes, commonly used in the field of computational neuroscience to analyze binary spikes.
These analytical methods have been explained elsewhere in detail 3,14,17,18 and see Figure 6 for explanation of the analytical pipeline and proposed visualization to aid clinical interpretation. Here, we use the Gamma parameter plane spanned by the shape and scale parameters of the Gamma PDFs that we empirically estimate from the MMS waveforms. We also plot the points of the corresponding Gamma moments on a four-dimensional graph, whereby the mean, variance and skewness span three of the dimensions and the kurtosis is represented in the size of the marker that we use to denote the person's stochastic signatures.
For each task, the MMS peak data derived from the biophysical time series are gathered and fitted to a Gamma PDF using maximum likelihood estimation (MLE) with 95% confidence intervals for each Gamma-parameter: the shape denoting the distribution's shape, and the scale denoting the dispersion (noise to signal ratio). As such, we estimate with high confidence, the best continuous family of PDFs that captures the biorhythms fluctuations of the person's nervous systems across different levels of functionality that these tasks demand. These functional layers span from high-level abstract cognitive skills and memory abilities, to voluntary neuromotor control and spontaneous consequential motions derived from the goal-directed tasks. We also examine automatic motions and the system's capacity for physical entrainment with the metronome's beats per minute. . (E) Probability density functions (PDF) fitting the frequency histogram evolving in time from the memory less, most random, exponential distribution (red) to some transitional skewed distribution (blue), to the Gaussian (predictive) with low dispersion (GOAL, green circle). This ideal distribution (green) appears in young athletes and sets the target for predictive, high signal-to-noise ratio cases. (F) Maximum likelihood estimation (MLE) used to fit the best PDF (with 95% confidence) to the empirical data. Resulting parameter values localize on the Gamma parameter plane the evolving stochastic signatures (Gamma process) from the COM speed fluctuations: "log shape" represents the shape of the distribution ranging from exponential to skewed to symmetric (ideal Gaussian); "log scale" is the noise-to-signal ratio (dispersion) implying the type of kinesthetic feedback the brain (most likely) gets 22, 23 . Colors represent stochastic states as they dynamically evolve over time. (G) Probability distance (Wasserstein metric distance 7 ) from the ideal GOAL of low noise-to-signal ratio (low dispersion) and high predictability (symmetric distribution) found in neurotypicals; away from poor feedback (random noise) found in more advanced PD, deafferented patients 24, 25, 26, 27 , schizophrenia 28 and autistic individuals 3, 18, 22, 29 . 
Results from Different Modes of Data
For the purpose of this paper, we examined three PWP and three healthy participants' data with the demographics shown in In the cognitive and memory test (pen movement), the positional trajectories of the pen motions were recorded, and the linear velocity was extracted to derive the time series of the speed amplitude. Then the MMS from the fluctuations in speed amplitude were derived for each drawing task. The patients were grouped according to the Movement Disorder Society−UPDRS (MDS-UPDRS) median ranked scores, with highest PD severity indicated by the highest ranked score above the median value of the cohort. Three representative participants from each cluster that the median ranking of the scores determined are used to display the results in relation to three representative controls. One control is young (26-year-old male) representing an ideal state of neuromotor control during youth. The other two are healthy aging controls; one 65-yearold female and one 67-year-old male. Figure 7 depicts the trajectories of COM and Figure 8 depicts the corresponding Gamma processes from the MMS derived from its trajectory speed profiles. Figure 8 shows the results from the best MLE fitted Gamma-PDF with 95% confidence for the healthy participants and patient participants. In each drawing task, the patients stratified apart from the controls. Further, they stratified within their group and differentiated according to the MDS-UPDRS median-ranked scores. Each patient is represented as the moments of the empirically estimated PDF on the top panels, while the bottom panels depict the PDF curves for each participant. Across panels, the reader can appreciate the family of PDFs spanned by each person across the tasks. Contrast this approach with the one-size-fits all (assumed) parametric models. Figure 8D shows the continuous drawing of the clock figure (task 6) as captured by the tip of the pen (including pen lifts).
By aligning the biophysical digital data with the clinical criteria this way, we provide an interpretable set of criteria that can more dynamically track individualized shifts in outcomes. We coin these new outcome measures dynamic digital biomarkers, because they are based on digital data, yet they provide interpretable outcomes according to well established and validated clinical criteria. They are derived from the time series of nervous system processes, and they capture the dynamic nature of such. In particular, we are able to use both motor and non-motor criteria. As such, we can begin to quantify non-motor aspects of PD that are now known to precede the deterioration of motor symptoms that conventionally have defined the disorder thus far. For example, facial analyses such as those presented here could be used to examine spontaneous facial micro-gestures during REM sleep to build a repertoire of those which could forecast the deterioration of motor activities. Likewise, we could use these methods to examine levels of pain during daily activities and assess their potential correlates with activities during REM sleep time. This is important, because both REM sleep and pain dysregulation are known to precede motor issues later defining the level of severity of PD 5, 6, 7 . Using our digitization of the various traditional clinical tasks, other non-motor activities embedded in the clinical tasks used to probe cognitive and memory abilities were characterized here, and indexes of such activities mapped to motor symptoms. These methods are amenable to connect basic research and clinical practices in Parkinson's disease. They can also be extended to other disorders of the nervous systems.
Besides motor output from the face, during REM sleep, we can examine facial gestures during natural social situations within the frame of self-sensing or kinesthetic reafference to gauge the levels of reafferent feedback the brain of the patient most likely gets. Here, despite the very subtle differences in micro-gestures across the facial areas corresponding to the trigeminal afferent regions V1, V2, V3, it was possible to pinpoint in the representative participant, which region of the face maximally shifted the stochastic signatures when transitioning between neutral and naturally smiling states. This suggests that using the SPIBA and the MMS, we will be able to evaluate other non-motor(sensory) aspects of PD related to difficulties with sensory input from kinesthetic-touch channels. These have been found to be problematic in PD, even during early stages of the disorder 24 . Because sensory and motor go hand in hand, this information could help us forecast more obvious motor issues surfacing later in the progression of this disorder 1, 7 . We posit that these kinesthetic channels along trigeminal areas of the face may also help us dissociate different types of pain dysregulation, including those related to sleep alterations 5, 6 .
The current methods provide a new way to examine the biophysical signals obtained from the central, peripheral and autonomic nervous systems in tandem, under different conditions requiring different cognitive skills and different levels of autonomy and neuromotor control. Using the SPIBA framework, where stochastic analyses and pair-wise network analyses are applied on the standardized MMS data, it is also possible to objectively characterize cognitive activities. The fifteen tasks that were used in this experiment require different types of cognitive skills (e.g., visuo-constructional skills, visual memory, perceptual-scanning skills) and different levels of cognitive control (e.g., deliberately pace the pointing speed, pace the breathing rate as instructed). For that reason, the stochasticity and connectivity patterns of CNS-PNS-ANS information transmission of biophysical signals exhibited during these tasks, can be used to characterize different levels of cognitive loads and their impact on the motor output.
While we underscore the advantages of our new analytical methods and protocols, we also point out caveats and practical limitations that ought to be considered when adopting our recording platform for synchronous data gathering. This is because in this set up, there are multiple recording software types streaming on a single computer for synchronization purposes, requiring the computational power of the computer to be high, or else one could incur data loss, computer freezing and/or excess noise. In the current design, two streaming software (EEG, and motion capture) and LSL were run on a single computer. As such, we had to be mindful of processing overload and possible computer freeze. This was one of the reasons why we used one of the EEG channels to extract the ECG signals. Computers with higher memory capacity and faster processors may be able to handle a separate ECG software simultaneously streaming with the EEG and sensor grid of kinematics. These issues are practical in nature and independent of the analytical methods (SPIBA) and standard data types (MMS) that we offer. Yet, we believe it is important to alert the end user of the need to assess computational power before designing the protocol for data co-registration from multiple streams.
Another caveat we point out is that, the 15 tasks illustrated in the protocol are a subset of what can be used to develop dynamic digital biomarkers. For the purpose of this paper, we limited to a few tasks due to space constraint, and chose the ones that involved different levels of control and bodily motion, and indeed we can add other tasks not included in this paper. Our goal is to derive a smaller subset of tasks that would require less time and effort. In fact, from our lab, pointing tasks (tasks 10−12) are a set of tasks that we found to be an effective and efficient way to characterize the stochastic signatures of biorhythms varied by differing levels of voluntary control and neurological disorders, including PD 24, 30 .
The representative results shown in this study are a small subset of what can be done with the MMS datasets derived from biosensors waveforms and cameras' motion caption, using SPIBA methods. For illustrative purposes, we examined the MMS in amplitude and focused on the fluctuations in the linear speed amplitude derived from the person's COM. The COM is a summary signal from all 17 body sensors grid that we co-registered. However, we could extend the analyses to other rotational parameters, and to other kinetic variables (e.g., forces and pressure) that generate time series of fluctuating parameters (e.g., as we did with the face data.) Also, due to space constraint, we only illustrated the analysis of EEG data based on its scalp amplitude information, but we can also apply these analytics to data derived from the source space 31 . For all modes of data, we could also examine the stochasticity of the times between peaks (instead of peak amplitude), which also generate time series. Other time series of parameters can be derived from such waveforms, and their MMS can be used to ascertain cohesiveness and connectivity from the network that was constructed 32, 33, 34 . Furthermore, these analyses can also be extended to the frequency domain 34 . In addition to the mutual information network analysis, we could have focused on other topological features of the network to differentiate PWP and controls and to stratify PWP. For the purpose of this paper, we focus on the usefulness of these analytics as a tool, but through this type of characterization, we will gain knowledge to provide clinically-informed interpretations of the digital data that these analytical tools provide.
The current methods described in this study serve to introduce some of the many possible ways that SPIBA and the MMS can be applied to clinical and digital data integration. We offer this unifying platform, standardized data type and experimental protocol in the hopes to finally inform digital data of clinical criteria, and likewise add more precision from the digital data to the traditional pencil-and-paper methods. Such improvement will 1) enable more accurate tracking of symptom change in response to treatment, 2) enhance understanding of natural PD progression over time, and 3) facilitate stratification of PD symptom presentation (which may dictate unique clinical recommendations for each subgroup). As such, we hope to apply these methods to further research in PD, but also see usefulness in clinical application as well. Using commercial-grade devices such as mobile phones, biophysical data can be obtained to perform the analytics that we illustrated in this paper. Currently, there are efforts in collecting such digital data on a larger scale such as the mPower app study from University of Rochester (https:// parkinsonmpower.org) and Kaggle. Indeed, using these open-access data repositories, we were able to stratify PD and normal aging individuals from accelerometer data obtained from mobile phones, and to automatically classify activities that are embedded in the clinical tests presented here 35 .
As a next step, we aim to collect more data from a wider range of PWP population and their matched control participants and record them at different time points to be able to perform both a cross-sectional and longitudinal analysis using our methods. We foresee such collected digital data would offer much more than the sum of their parts, and truly realize the tenets of precision medicine in neurology and psychiatry.
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